Nucleic Acids Research, ISSN 0305-1048, 09/2016, Volume 44, Issue 16, pp. e132 - e132
The quantification of transcriptomic features is the basis of the analysis of RNA-seq data. We present an integrated alignment workflow and a simple...
ACCURATE | ALIGNMENT | TRANSCRIPTOME | MODELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | NONUNIFORM READ DISTRIBUTION | GENOMIC FEATURES | INFERENCE | ISOFORM EXPRESSION | ABUNDANCE | Introns - genetics | Genes | Humans | Gene Expression Regulation | Exons - genetics | Statistics as Topic | Sequence Alignment | Sequence Analysis, RNA | Time Factors | Computer Simulation | Statistics, Nonparametric | Software | Quality Control | Methods Online
ACCURATE | ALIGNMENT | TRANSCRIPTOME | MODELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | NONUNIFORM READ DISTRIBUTION | GENOMIC FEATURES | INFERENCE | ISOFORM EXPRESSION | ABUNDANCE | Introns - genetics | Genes | Humans | Gene Expression Regulation | Exons - genetics | Statistics as Topic | Sequence Alignment | Sequence Analysis, RNA | Time Factors | Computer Simulation | Statistics, Nonparametric | Software | Quality Control | Methods Online
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 07/2015, Volume 11, Issue 7, pp. 511 - 517
Spinal muscular atrophy (SMA), which results from the loss of expression of the survival of motor neuron-1 (SMN1) gene, represents the most common genetic...
SURVIVAL | SYSTEM | PROTEIN | SPINAL MUSCULAR-ATROPHY | MESSENGER-RNA | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | IDENTIFICATION | EXPRESSION | BINDING | SINGLE NUCLEOTIDE | RNA Precursors - chemistry | Ribonucleoprotein, U1 Small Nuclear - metabolism | Small Molecule Libraries - pharmacology | Alternative Splicing | Humans | Small Molecule Libraries - metabolism | Survival of Motor Neuron 2 Protein - metabolism | Proteolysis | Survival of Motor Neuron 2 Protein - chemistry | Protein Binding - drug effects | Survival of Motor Neuron 2 Protein - genetics | Ribonucleoprotein, U1 Small Nuclear - chemistry | Female | RNA Precursors - metabolism | RNA, Double-Stranded - metabolism | Binding Sites | RNA, Double-Stranded - chemistry | Disease Models, Animal | RNA, Double-Stranded - agonists | Muscular Atrophy, Spinal - mortality | Gene Expression | Muscular Atrophy, Spinal - metabolism | Ribonucleoprotein, U1 Small Nuclear - agonists | Models, Molecular | Small Molecule Libraries - chemical synthesis | Mice, Transgenic | RNA Precursors - agonists | Muscular Atrophy, Spinal - pathology | Animals | Protein Stability - drug effects | Survival Analysis | Muscular Atrophy, Spinal - drug therapy | Mice | Molecular biology | Rodents | Neurological disorders
SURVIVAL | SYSTEM | PROTEIN | SPINAL MUSCULAR-ATROPHY | MESSENGER-RNA | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | IDENTIFICATION | EXPRESSION | BINDING | SINGLE NUCLEOTIDE | RNA Precursors - chemistry | Ribonucleoprotein, U1 Small Nuclear - metabolism | Small Molecule Libraries - pharmacology | Alternative Splicing | Humans | Small Molecule Libraries - metabolism | Survival of Motor Neuron 2 Protein - metabolism | Proteolysis | Survival of Motor Neuron 2 Protein - chemistry | Protein Binding - drug effects | Survival of Motor Neuron 2 Protein - genetics | Ribonucleoprotein, U1 Small Nuclear - chemistry | Female | RNA Precursors - metabolism | RNA, Double-Stranded - metabolism | Binding Sites | RNA, Double-Stranded - chemistry | Disease Models, Animal | RNA, Double-Stranded - agonists | Muscular Atrophy, Spinal - mortality | Gene Expression | Muscular Atrophy, Spinal - metabolism | Ribonucleoprotein, U1 Small Nuclear - agonists | Models, Molecular | Small Molecule Libraries - chemical synthesis | Mice, Transgenic | RNA Precursors - agonists | Muscular Atrophy, Spinal - pathology | Animals | Protein Stability - drug effects | Survival Analysis | Muscular Atrophy, Spinal - drug therapy | Mice | Molecular biology | Rodents | Neurological disorders
Journal Article
BMC Genomics, ISSN 1471-2164, 06/2017, Volume 18, Issue 1, pp. 442 - 13
Background: RNA-sequencing (RNA-seq) has emerged as one of the most sensitive tool for gene expression analysis. Among the library preparation methods...
Low quality | RNA-sequencing | Benchmarking | Expression profiling | Differential expression | Low quantity | CELLS | MICROARRAY | QUANTIFICATION | IDENTIFICATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | GENE-EXPRESSION | HUMAN TRANSCRIPTOME | CAPTURE | REVEALS | Sequence Analysis, RNA - methods | Sequence Alignment | Humans | RNA, Messenger - genetics | RNA, Messenger - chemistry | Taq Polymerase - metabolism | RNA Stability | RNA, Messenger - metabolism | Quality Control | RNA sequencing | Research | Gene expression | Ribosomal RNA | Performance evaluation | Poly(A) | rRNA | Genomics | Genomes | Gene sequencing | Degradation | Consortia | Studies | Depletion | Ribonucleic acids | Polyadenylation | Quality control | Libraries | Kits | Methods
Low quality | RNA-sequencing | Benchmarking | Expression profiling | Differential expression | Low quantity | CELLS | MICROARRAY | QUANTIFICATION | IDENTIFICATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | GENE-EXPRESSION | HUMAN TRANSCRIPTOME | CAPTURE | REVEALS | Sequence Analysis, RNA - methods | Sequence Alignment | Humans | RNA, Messenger - genetics | RNA, Messenger - chemistry | Taq Polymerase - metabolism | RNA Stability | RNA, Messenger - metabolism | Quality Control | RNA sequencing | Research | Gene expression | Ribosomal RNA | Performance evaluation | Poly(A) | rRNA | Genomics | Genomes | Gene sequencing | Degradation | Consortia | Studies | Depletion | Ribonucleic acids | Polyadenylation | Quality control | Libraries | Kits | Methods
Journal Article
GENOME BIOLOGY, ISSN 1474-760X, 07/2019, Volume 20, Issue 1, p. 142
We develop CellSIUS (Cell Subtype Identification from Upregulated gene Sets) to fill a methodology gap for rare cell population identification for scRNA-seq...
Choroid plexus | Data analysis | REELIN | TRAJECTORIES | Benchmarking | Rare cell types | Clustering | IDENTITY | HETEROGENEITY | CORTICAL-NEURONS | Single-cell RNA sequencing | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PACKAGE | GENETICS & HEREDITY | Cortical development | Software | Human pluripotent stem cells | SEQUENCING DATA | Lineage mapping | EXPRESSION | Biomedical research | Genomics | Population studies | Identification | Genomes | Ribonucleic acid--RNA | Gene expression | Cell differentiation | Datasets | Archives & records | Stem cells | Quality control | Cell cycle | Bioinformatics | Pluripotency
Choroid plexus | Data analysis | REELIN | TRAJECTORIES | Benchmarking | Rare cell types | Clustering | IDENTITY | HETEROGENEITY | CORTICAL-NEURONS | Single-cell RNA sequencing | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PACKAGE | GENETICS & HEREDITY | Cortical development | Software | Human pluripotent stem cells | SEQUENCING DATA | Lineage mapping | EXPRESSION | Biomedical research | Genomics | Population studies | Identification | Genomes | Ribonucleic acid--RNA | Gene expression | Cell differentiation | Datasets | Archives & records | Stem cells | Quality control | Cell cycle | Bioinformatics | Pluripotency
Journal Article
6.
Full Text
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
BMC Genomics, ISSN 1471-2164, 09/2016, Volume 17, Issue 1
Background: Genome-wide CRISPR-Cas9 dropout screens can identify genes whose knockout affects cell viability. Recent CRISPR screens detected thousands of...
NRAS | Driver mutations | Kinase | Negative selection | EGFR | Whole genome CRISPR screen | Dropout | CELLS | DISCOVERY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GROWTH | GENES | GENETICS & HEREDITY | Genome-wide association studies | Usage | Research | Gene mutations | Cancer cells
NRAS | Driver mutations | Kinase | Negative selection | EGFR | Whole genome CRISPR screen | Dropout | CELLS | DISCOVERY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GROWTH | GENES | GENETICS & HEREDITY | Genome-wide association studies | Usage | Research | Gene mutations | Cancer cells
Journal Article
Neurology, ISSN 0028-3878, 03/2012, Volume 78, Issue 10, pp. 690 - 695
Objective: Age at onset of diagnostic motor manifestations in Huntington disease (HD) is strongly correlated with an expanded CAG trinucleotide repeat. The...
HOMOZYGOSITY | ALLELE | OF-ONSET | GENE | LENGTH | MUTATION | CHROMOSOMES | CLINICAL NEUROLOGY | TRINUCLEOTIDE REPEAT | Humans | Age of Onset | Alleles | Huntington Disease - genetics | Adult | Female | Genotype | Huntington Disease - diagnosis | Male | Trinucleotide Repeat Expansion | 164
HOMOZYGOSITY | ALLELE | OF-ONSET | GENE | LENGTH | MUTATION | CHROMOSOMES | CLINICAL NEUROLOGY | TRINUCLEOTIDE REPEAT | Humans | Age of Onset | Alleles | Huntington Disease - genetics | Adult | Female | Genotype | Huntington Disease - diagnosis | Male | Trinucleotide Repeat Expansion | 164
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 2019, Volume 15, Issue 2, pp. 179 - 179
The identification of activating mutations in NOTCH1 in 50% of T cell acute lymphoblastic leukemia has generated interest in elucidating how these mutations...
MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | DRUG DISCOVERY | RESISTANCE | GAMMA-SECRETASE INHIBITORS | ZINC TRANSPORTERS | ENDOPLASMIC-RETICULUM | TARGET IDENTIFICATION | OPINION | ACTIVATING MUTATIONS | PREDICTION | Transformation | Sequences | Acute lymphatic leukemia | Target recognition | Leukemia | Trafficking | Lymphocytes T | Lymphatic leukemia | Zinc | Organic chemistry | Zinc compounds | Lymphocytes | Mutation | Endoplasmic reticulum | Apoptosis
MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | DRUG DISCOVERY | RESISTANCE | GAMMA-SECRETASE INHIBITORS | ZINC TRANSPORTERS | ENDOPLASMIC-RETICULUM | TARGET IDENTIFICATION | OPINION | ACTIVATING MUTATIONS | PREDICTION | Transformation | Sequences | Acute lymphatic leukemia | Target recognition | Leukemia | Trafficking | Lymphocytes T | Lymphatic leukemia | Zinc | Organic chemistry | Zinc compounds | Lymphocytes | Mutation | Endoplasmic reticulum | Apoptosis
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2017, Volume 7, Issue 1, p. 42728
Chemogenomic profiling is a powerful and unbiased approach to elucidate pharmacological targets and the mechanism of bioactive compounds. Until recently,...
TARGET | SCREENS | CANCER | MYC | MULTIDISCIPLINARY SCIENCES | NADPH | CRISPR | Clonal deletion | Bioactive compounds | Hypersensitivity | Nicotinamide phosphoribosyltransferase | Genomes | Mammalian cells
TARGET | SCREENS | CANCER | MYC | MULTIDISCIPLINARY SCIENCES | NADPH | CRISPR | Clonal deletion | Bioactive compounds | Hypersensitivity | Nicotinamide phosphoribosyltransferase | Genomes | Mammalian cells
Journal Article
ELIFE, ISSN 2050-084X, 12/2017, Volume 6
Plasmodium liver hypnozoites, which cause disease relapse, are widely considered to be the last barrier towards malaria eradication. The biology of this...
TARGET | HOMEOSTASIS | TRANSPORTER | FALCIPARUM | PERSISTENCE | COMPOUND | BIOLOGY | HYPNOZOITE | ACTS | Plasmodium cynomolgi - growth & development | Animals | Schizonts - genetics | Plasmodium cynomolgi - genetics | Female | Male | Schizonts - growth & development | Gene Expression Profiling | Macaca mulatta - parasitology | Liver - parasitology | Plasmodium falciparum | Relapse | Malaria | Analysis | Liver | Genomics | Physiological aspects | Genomes | Drug discovery | Diseases | Schizonts | Liver diseases | Homeostasis | Infections | Parasites | Artificial chromosomes | Gene expression | Heavy metals | Tropical diseases | Dormancy | Archives & records | Physiology
TARGET | HOMEOSTASIS | TRANSPORTER | FALCIPARUM | PERSISTENCE | COMPOUND | BIOLOGY | HYPNOZOITE | ACTS | Plasmodium cynomolgi - growth & development | Animals | Schizonts - genetics | Plasmodium cynomolgi - genetics | Female | Male | Schizonts - growth & development | Gene Expression Profiling | Macaca mulatta - parasitology | Liver - parasitology | Plasmodium falciparum | Relapse | Malaria | Analysis | Liver | Genomics | Physiological aspects | Genomes | Drug discovery | Diseases | Schizonts | Liver diseases | Homeostasis | Infections | Parasites | Artificial chromosomes | Gene expression | Heavy metals | Tropical diseases | Dormancy | Archives & records | Physiology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2013, Volume 57, Issue 5, pp. 2272 - 2280
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
YEAST | SURVIVAL | ACETOHYDROXYACID SYNTHASE | PATHWAY | BIOSYNTHESIS | DRUG DISCOVERY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CHAIN AMINO-ACIDS | VIRULENCE | Catalytic Domain - drug effects | Serum - metabolism | Saccharomyces cerevisiae - genetics | Amino Acids, Branched-Chain - metabolism | Humans | Saccharomyces cerevisiae - drug effects | Antifungal Agents - chemistry | Sulfonylurea Compounds - chemistry | Pyrimidines - chemistry | Acetolactate Synthase - chemistry | Microbial Sensitivity Tests | Sulfonylurea Compounds - pharmacology | Acetolactate Synthase - genetics | Antifungal Agents - pharmacology | Sulfonamides - chemistry | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Pyrimidines - pharmacology | Saccharomyces cerevisiae Proteins - genetics | Sulfonamides - pharmacology | High-Throughput Screening Assays | Amino Acids, Branched-Chain - pharmacology | Saccharomyces cerevisiae Proteins - metabolism | Protein Binding | Saccharomyces cerevisiae - enzymology | Acetolactate Synthase - metabolism | Molecular Docking Simulation | Mutation | Acetolactate Synthase - antagonists & inhibitors | Saccharomyces cerevisiae Proteins - chemistry | Serum - chemistry | Index Medicus | Mechanisms of Action | Physiological Effects
YEAST | SURVIVAL | ACETOHYDROXYACID SYNTHASE | PATHWAY | BIOSYNTHESIS | DRUG DISCOVERY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CHAIN AMINO-ACIDS | VIRULENCE | Catalytic Domain - drug effects | Serum - metabolism | Saccharomyces cerevisiae - genetics | Amino Acids, Branched-Chain - metabolism | Humans | Saccharomyces cerevisiae - drug effects | Antifungal Agents - chemistry | Sulfonylurea Compounds - chemistry | Pyrimidines - chemistry | Acetolactate Synthase - chemistry | Microbial Sensitivity Tests | Sulfonylurea Compounds - pharmacology | Acetolactate Synthase - genetics | Antifungal Agents - pharmacology | Sulfonamides - chemistry | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Pyrimidines - pharmacology | Saccharomyces cerevisiae Proteins - genetics | Sulfonamides - pharmacology | High-Throughput Screening Assays | Amino Acids, Branched-Chain - pharmacology | Saccharomyces cerevisiae Proteins - metabolism | Protein Binding | Saccharomyces cerevisiae - enzymology | Acetolactate Synthase - metabolism | Molecular Docking Simulation | Mutation | Acetolactate Synthase - antagonists & inhibitors | Saccharomyces cerevisiae Proteins - chemistry | Serum - chemistry | Index Medicus | Mechanisms of Action | Physiological Effects
Journal Article
Nature Communications, ISSN 2041-1723, 10/2015, Volume 6, Issue 1, p. 8613
FR171456 is a natural product with cholesterol-lowering properties in animal models, but its molecular target is unknown, which hinders further drug...
DRUG | ACID | MINIMA NO. 15604 | MULTIDISCIPLINARY SCIENCES | TARGETS | IDENTIFICATION | SACCHAROMYCES-CEREVISIAE | CHOLESTEROL-BIOSYNTHESIS | Candida albicans | Cholesterol - chemistry | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Cholesterol - analogs & derivatives | Saccharomyces cerevisiae - genetics | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Ergosterol - biosynthesis | Antifungal Agents - chemistry | Drug Resistance, Fungal - genetics | Mutation | Saccharomyces cerevisiae Proteins - genetics | 3-Hydroxysteroid Dehydrogenases - genetics
DRUG | ACID | MINIMA NO. 15604 | MULTIDISCIPLINARY SCIENCES | TARGETS | IDENTIFICATION | SACCHAROMYCES-CEREVISIAE | CHOLESTEROL-BIOSYNTHESIS | Candida albicans | Cholesterol - chemistry | 3-Hydroxysteroid Dehydrogenases - antagonists & inhibitors | Cholesterol - analogs & derivatives | Saccharomyces cerevisiae - genetics | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Ergosterol - biosynthesis | Antifungal Agents - chemistry | Drug Resistance, Fungal - genetics | Mutation | Saccharomyces cerevisiae Proteins - genetics | 3-Hydroxysteroid Dehydrogenases - genetics
Journal Article
eLife, ISSN 2050-084X, 12/2018, Volume 7
Relapses of Plasmodium dormant liver hypnozoites compromise malaria eradication efforts. New radical cure drugs are urgently needed, yet the vast gap in...
maturation | infectious disease | plasmodium | microbiology | transcriptomics | liver stages | malaria | hypnozoites | TARGET | LIVER-STAGE DEVELOPMENT | PROTEIN | COMMITMENT | VIVAX | PERSISTENCE | BIOLOGY | TOXOPLASMA-GONDII | TRANSLOCON | IDENTIFICATION | DISCOVERY | Plasmodium cynomolgi - growth & development | Animals | Time Factors | Plasmodium cynomolgi - genetics | Primates | Gene Expression Profiling | Liver - parasitology | Energy metabolism | Malaria | Disease | Transcription | Liver | Infections | Genomes | Biology | Parasites | Gene expression | Kinases | Tropical diseases | Dormancy | Quality
maturation | infectious disease | plasmodium | microbiology | transcriptomics | liver stages | malaria | hypnozoites | TARGET | LIVER-STAGE DEVELOPMENT | PROTEIN | COMMITMENT | VIVAX | PERSISTENCE | BIOLOGY | TOXOPLASMA-GONDII | TRANSLOCON | IDENTIFICATION | DISCOVERY | Plasmodium cynomolgi - growth & development | Animals | Time Factors | Plasmodium cynomolgi - genetics | Primates | Gene Expression Profiling | Liver - parasitology | Energy metabolism | Malaria | Disease | Transcription | Liver | Infections | Genomes | Biology | Parasites | Gene expression | Kinases | Tropical diseases | Dormancy | Quality
Journal Article